Entry |
|
Name |
Amyl nitrite (JP18/USP); Aspiral (TN); Vaporole (TN) |
Formula |
C5H11NO2
|
Exact mass |
117.0790
|
Mol weight |
117.15
|
Structure |

|
Simcomp |
|
Class |
Cardiovascular agent
DG01657 Nitrovasodilator
|
Remark |
|
Efficacy |
Antidote (cyanide), Vasodilator, Guanylate cyclase activator |
Disease |
|
Comment |
Antidote (cyanide poisoning)
|
Target |
|
Pathway |
hsa04270 | Vascular smooth muscle contraction |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
V VARIOUS
V03 ALL OTHER THERAPEUTIC PRODUCTS
V03A ALL OTHER THERAPEUTIC PRODUCTS
V03AB Antidotes
V03AB22 Amyl nitrite
D00517 Amyl nitrite (JP18/USP) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
217 Vasodilators
2179 Others
D00517 Amyl nitrite (JP18/USP)
3 Agents affecting metabolism
39 Other agents affecting metabolism
392 Antidotes
3929 Others
D00517 Amyl nitrite (JP18/USP)
Drug groups [BR:br08330]
Cardiovascular agent
DG01657 Nitrovasodilator
D00517 Amyl nitrite
Target-based classification of drugs [BR:br08310]
Enzymes
Lyases (EC4)
Phosphorus-oxygen lyases
GUCY1A
D00517 Amyl nitrite (JP18/USP) <JP>
GUCY1B
D00517 Amyl nitrite (JP18/USP) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00517 Amyl nitrite
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 8
1 C1b C 20.0224 -18.4495
2 C1b C 21.2325 -17.7455
3 C1c C 18.8120 -17.7455
4 O2a O 22.4429 -18.4495
5 C1a C 17.6018 -18.4495
6 C1a C 18.8120 -16.3431
7 N2b N 23.6531 -17.7455
8 O3a O 24.8633 -18.4436
BOND 7
1 1 2 1
2 1 3 1
3 2 4 1
4 3 5 1
5 3 6 1
6 4 7 1
7 7 8 2
|